Conventional clinical risk factors are currently used to assess fracture risk, but genome-wide association studies conducted in the past decade have identified genetic variants associated with fracture risk. This Review discusses the potential of integrating genetic profiling into existing risk assessment models for the individualization of fracture risk prediction.
- Tuan V. Nguyen
- John A. Eisman
